Oral Immunization with a Recombinant Malaria Protein Induces Conformational Antibodies and Protects Mice against Lethal Malaria
- 1 May 2003
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 71 (5) , 2356-64
- https://doi.org/10.1128/iai.71.5.2356-2364.2003
Abstract
The increasing death toll from malaria, due to the decreasing effectiveness of current prophylactic and therapeutic regimens, has sparked a search for alternative methods of control, such as vaccines. Although several single proteins have shown some promise as subunit vaccines against sexual blood stages in experimental systems, it is clear that multicomponent vaccines are required. Many logistic difficulties make such an approach prohibitively expensive. In an effort to try to overcome some of these issues, we examined the possibility of oral immunization as a route for inducing host protective immunity. We report here that oral feeding of a malaria protein induced serum antibody levels similar to those induced by intraperitoneal immunization with Freund's adjuvant. Further, responses to conformational epitopes were induced. In the rodent challenge system, significant levels of protection to lethal challenge with malaria were induced in mice. The protective efficacy was highly correlated with antibody levels, which depended on the antigen dosage and required cholera toxin subunit B as an oral adjuvant. These findings offer new approaches to the development of a malaria vaccine and provide justification for the investigation of transgenic plants as a means of vaccine delivery.Keywords
This publication has 25 references indexed in Scilit:
- Naturally Acquired Antibody Responses toPlasmodium falciparumMerozoite Surface Protein 4 in a Population Living in an Area of Endemicity in VietnamInfection and Immunity, 2001
- Merozoite surface protein 8 of Plasmodium falciparum contains two epidermal growth factor-like domainsMolecular and Biochemical Parasitology, 2001
- Dose-Dependent Circulating Immunoglobulin A Antibody-Secreting Cell and Serum Antibody Responses in Swedish Volunteers to an Oral Inactivated Enterotoxigenic Escherichia coli VaccineClinical and Diagnostic Laboratory Immunology, 2001
- Immunization with RecombinantPlasmodium yoeliiMerozoite Surface Protein 4/5 Protects Mice against Lethal ChallengeInfection and Immunity, 2000
- Characterisation of the merozoite surface protein 4/5 gene of Plasmodium berghei and Plasmodium yoeliiMolecular and Biochemical Parasitology, 2000
- Intranasal immunization with yeast‐expressed 19 kD carboxyl‐terminal fragment of Plasmodium yoelii merozoite surface protein‐1 (yMSP119) induces protective immunity to blood stage malaria infection in miceParasite Immunology, 1998
- Affinity purification of recombinant cholera toxin B subunit oligomer expressed inBacillus brevisfor potential human use as a mucosal adjuvantFEMS Immunology & Medical Microbiology, 1998
- Immunization against malaria with a recombinant proteinParasite Immunology, 1994
- Cholera toxin and cholera B subunit as oral—mucosal adjuvant and antigen vector systemsVaccine, 1993
- The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor.The Journal of Experimental Medicine, 1984